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Abstract
As an endothelium-derived relaxing factor, nitric oxide (NO) maintains blood flow and O2 transport to tissues. Under
normal conditions a delicate balance exists in the vascular system between endothelium-derived NO, an antioxidant, and the
pro-oxidant elements of the vascular system, O32 , and peroxynitrite (a by-product of the reaction of NO and superoxide); in
addition there is a balance between neurogenic tonic contraction and NO-mediated relaxation. The former balance can be
disrupted in favor of peroxynitrite and hydrogen peroxide under the conditions of ischemia/reperfusion. This review suggests
that NO may be beneficial, not only in terms of its new potential in improving O2 transport without accompanying
significant increase in tissue blood flow, but also in its ability to suppress the prooxidative reagents of the vascular systems.
These include NO-mediated inhibition of transendothelial migration by leukocyte and the antioxidative effects of NO with
regard to ischemia/reperfusion; the relevance of these hypotheses to systemic administration of NO donors is
discussed. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
The group of Tannenbaum [1] reported that Es-
cherichia coli lipopolysaccharide (LPS) induced the
synthesis of the nitric oxide (NO) end products, ni-
trite and nitrate, in rats, after a time delay of a few
hours and the phenomenon was studied in vitro us-
ing macrophages by Stuehr and Marletta [2], and by
Hibbs et al. [3]. NO was found later to mediate mul-
tiple functions such as relaxation of blood vessels,
inhibition of platelet aggregation, and neurotrans-
mission [4].
NO bound to Hb (HbNO) is stable under anaero-
bic conditions in vitro, but not in aerobic conditions
due to its conversion to methemoglobin. Although
the partial pressure of oxygen in blood is more
than 40 mmHg of O2, HbNO has been detected by
electron spin (paramagnetic) resonance (ESR, EPR)
spectroscopy in blood of rats treated with LPS [5^7]
and also in the blood of rats during immune rejection
of allograft. The stable nature of HbNO in vivo is
somewhat of a mystery.
The reaction between NO and oxyhemoglobin
(oxyferrous Hb) results in the rapid formation of
methemoglobin (ferric Hb) and this is now used as
an NO assay [9]. On the other hand, the reaction
between NO and deoxyhemoglobin (ferrous Hb)
does not make methemoglobin, but NO-hemoglobin
(NO ferrous Hb) [10^13]. NO-hemoglobin is stable in
the absence of O2, but the introduction of O2 slowly
oxidizes NO-hemoglobin [14]. NO-hemoglobin can
be detected with EPR since NO has an unpaired
electron. Whether NO is bound to Hb K- or L-sub-
unit can be easily determined since they show distinct
EPR spectra [8]. In addition, under the right condi-
tions a three-line hyper¢ne structure can be detected
in K-, but not L-, NO hemes. It appears due to an
interaction between the unpaired electron and the
nuclear spin of the NO nitrogen. This occurs only
if Hb is in the low a⁄nity tense state (T state) qua-
ternary structure as in deoxyhemoglobin, since a
heme iron-proximal histidine bond in Hb K-NO sub-
unit is broken or stretched (5-coordinated) in the
T state (Fig. 1, bottom). On the contrary, if Hb
K-NO is in the high a⁄nity relaxed state (R state)
as in oxyhemoglobin, it shows no three-line hyper¢ne
structure since the heme iron is hexacoordinate (Fig.
1, top). Under these conditions additional overlap-
ping hyper¢ne interactions with the nitrogen of the
proximal histidine ligand result in a less well-de¢ned
EPR spectrum.
EPR spectroscopy of HbNO in rat venous blood
demonstrated that NO bound primarily to the K-sub-
unit, and that similar concentrations of Hb K-NO
were detected in arterial blood and venous blood.
However, the spectral shapes were distinct, with the
three-line spectrum dominating in the venous blood.
This could be attributed to the arterio-venous allos-
teric change between the R and T state [8,15], with
the T state exhibiting the 5-coordinate three-line
spectrum (Fig. 1). The reversible transition between
the 5-coordinate and 6-coordinate forms of the Hb
K-NO species suggests the possibility that the parti-
ally NO-bound Hb K in erythrocytes could enhance
oxygen dissociation in other heme sites; when the Hb
K-NO is converted into the 5-coordinated form at
low oxygen pressure, it can a¡ect the R-T state tran-
sition since the heme iron-proximal histidine bonds
in the K-subunits play a role as the trigger for ligand-
induced tertiary structural change between the oxy-
genated and deoxygenated forms [16].
NO can bind to both Hb K- and L-subunits in the
R state [17]; however, as with other ligands, NO
prefers to bind to the Hb K-subunit in the T state.
The fraction of Hb K-NO was increased to nearly
100% at pH 7 by the allosteric e¡ector, inositol hexa-
phosphate, which preferentially binds to the T state
and is presumed to accelerate the dissociation of NO
from L-hemes because the a⁄nity of NO for L-hemes
is weaker than that for K-hemes in the T state [18].
As discussed previously, when a rat is subject to an
increase in NO production in the vasculature, the
arterial blood taken from the animal contains pre-
dominantly hexacoordinate Hb K-NO. However, if
the oxygen tension is then decreased in the blood
sample in vitro, the fraction of 5-coordinated K-NO
(Hb K-NO having the three-line hyper¢ne structure)
increases [8]. These results suggest that the partially
NO-bound Hb K in erythrocytes can enhance oxygen
dissociation from other heme sites, since it favors the
formation of the very low a⁄nity 5-coordinated
T state form in venous blood. This is despite a
mean oxygen saturation of 75% in the venous blood
(conditions where one would normally expect most
of Hb to be in the R state). In agreement with these
ideas the oxygen a⁄nity was found to be much lower
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in Hb having chemically modi¢ed 5-coordinated K-,
but not L-, heme [19].
Endogenous carbon monoxide (CO), a product of
heme oxygenase, is reported to up-regulate cGMP
production via activation of guanylate cyclase and
to share several biological actions with NO [20].
On the other hand, CO binds to Hb stronger than
O2. If a Hb tetramer in circulating erythrocytes traps
one molecule of CO so generated, it increases the
relative a⁄nity of other heme sites for oxygen. It
thus shifts the oxygen dissociation curve of erythro-
cytes to the left [21], i.e., CO decreases oxygen supply
to tissues. Because of the much higher a⁄nity of NO
for Hb than CO, it was originally considered and an
in vitro study suggested [22] that oxygen in the par-
tially NO-bound Hb tetramer would not readily dis-
sociate, similarly to oxygen in the partially CO-
bound Hb, i.e. NO would also be expected a priori
to left shift the oxygen dissociation curve. If true,
this would indicate that endogenous NO might in-
crease tissue hypoxia. On the contrary, however, it
has been demonstrated that NO increases O2 release
from hemoglobin and thus O2 supply to tissues [23],
Fig. 1. Selective binding of NO on the Hb K-subunit in vivo
and EPR spectral transition of Hb K-NO during arterial and
venous circulation. Respective schematic structures of K-heme
and Hb tetramer are shown on the right [8,25]. Blood was tak-
en from a rat treated with nitroglycerin.
Fig. 2. E¡ect of nitroglycerin on the rate of O2 release in single unbranched hepatic sinusoids of rats. (A) For the control groups (a),
rats were given intravenous infusions of physiological saline for 70 min. For the nitroglycerin groups, after the infusions of physiologi-
cal saline for 20 min, infusion of nitroglycerin solution was started at time 0 and continued for 50 min. All rats received the same vol-
ume of infusion at a rate of 6 ml/kg per h. Infusion rate of nitroglycerin (Wg/kg per h): b, 120; R, 60. Each point represents nine
rats. *P6 0.001 versus 5 min before nitroglycerin infusion. (B) Independence of O2 release rate from oxyhemoglobin (HbO2) in£ow in
single unbranched hepatic sinusoids in control and nitroglycerin-treated rats. a, control rats; E, before and b, after infusion of nitro-
glycerin (120 Wg/kg per h) [23].
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i.e. NO acts as a right shifter of the dissociation
curve. This seems to be reasonable for physiological
regulation since, if O2 dissociation from hemoglobin
were inhibited by NO, this would prevent the full
e¡ect of an NO-induced increase in blood £ow lead-
ing to increased O2 supply to tissues.
Nitrovasodilators have been used to improve
blood £ow by relaxing blood vessels. However, we
have recently shown that nitroglycerin also increases
O2 release from erythrocytes [23]. Since nitroglycerin
produced NO [24] and decreased the O2 a⁄nity of
Hb [25], NO can increase tissue O2 supply directly.
We proposed that one molecule of NO bound to Hb
K-heme can augment the allosteric decrease in O2
a⁄nity of the Hb tetramer in peripheral circulation.
A radically di¡erent proposal for NO control of
oxygen dissociation from Hb has been suggested by
Stamler et al. [26] who reported that NO causes
S-nitrosation of Hb L SH in the lung and the NO
dissociates in the peripheral circulation and relaxes
blood vessels, leading to an increase in blood £ow.
As nitroglycerin may give rise to S-nitrosylation in
addition to iron nitrosylation, the relative impor-
tance of these two e¡ects is not clear at present.
2. Increase in O2 release from hemoglobin by NO
As suggested previously, NO not only relaxes
blood vessels but also may increase O2 release from
hemoglobin. To test the physiological relevance of
this mechanism in vivo, we obtained O2 release rates
by monitoring O2 transport parameters at two sepa-
rate spots (approx. 70 Wm apart) on a single un-
branched microvessel (approx. 10 Wm diameter) in
the microscopic ¢eld of organs (dual-spot microspec-
troscopy) [23]. Measured O2 transport parameters
were erythrocyte velocity, Hb concentration, and dif-
ference in O2 saturation of Hb between upstream
and downstream spots in single unbranched hepatic
sinusoids, from which we obtained the O2 release
rate per unit area of the sinusoidal wall in rats.
Rats were ventilated with a respirator. After trans-
verse upper abdominal laparotomy, the liver was
placed on a transparent platform on the stage of a
microscope to obtain O2 release rate by the dual-spot
microspectroscopy and erythrocyte velocity accord-
ing to the dual-spot cross-correlation method on a
single unbranched hepatic sinusoid.
The rate of O2 release was constant in the control.
Nitroglycerin signi¢cantly increased O2 release (Fig.
Fig. 3. E¡ect of nitroglycerin on di¡erence in O2 saturation per
length. a, control studies. Infusion rate of nitroglycerin (Wg/kg
per h): b, 120; R, 60. Experimental conditions are as in Fig.
2. *P6 0.05; **P6 0.001 versus 5 min before nitroglycerin in-
fusion [23].
Fig. 4. Imaging of enhancing e¡ect of NO on Hb-facilitated
oxygen di¡usion. Lines were drawn on the data of Wittenberg
[28] except for Hb4(O2)3(K-NO).
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2A), although oxyhemoglobin (HbO2) in£ow and the
rate of O2 in£ow at the upstream spot in the sinusoid
did not signi¢cantly increase (Fig. 2B). Nitroglycerin
infusion did not signi¢cantly alter erythrocyte veloc-
ity and Hb concentration ([Hb]) in the hepatic sinus-
oids, but signi¢cantly increased the di¡erence in O2
saturation per unit length of the sinusoid (vSO2/L)
(Fig. 3). Furthermore, isosorbide dinitrate signi¢-
cantly increased O2 release and vSO2/L without in-
creasing the blood £ow. Release of O2 in the micro-
vessel was kept constant even if oxyhemoglobin £ow
rate was increased to near 200 fmol/s in the control
rat; this is as expected in this system since tissue O2
consumption was constant and below the level at
which it is regulated by increases in tissue oxygen
supply; if tissue O2 demand is greater than the O2
in£ow (e.g., in skeletal muscle during exercise) O2
release would depend on O2 in£ow. Fig. 2B shows
that there is a balance between the amount of O2
released from erythrocytes and the tissue O2 demand.
Thus O2 release from erythrocytes will be kept con-
stant if tissue O2 demand is not changed when nitro-
vasodilators are administered. In fact, no change was
noted by nitrovasodilators for hepatic O2 consump-
tion measured in isolated liver perfused with Hb-free
oxygenated bu¡er. On the contrary, nitrovasodila-
tors signi¢cantly increased O2 release from £owing
erythrocytes in hepatic sinusoids. This may be due
to a decrease in Hb O2 a⁄nity by Hb K-NO.
To prove this hypothesis, blood containing Hb
K-NO was obtained from rats. When Hb K-NO
was produced (up to 22 WM by administration of
nitroglycerin of 20 mg/kg i.p.), the O2 saturation of
the blood was signi¢cantly lower in parallel with the
decrease in pO2 (Table 1). Because Hb binds the NO
molecule in the K-subunit alone in vivo, there must
be approx. 22 WM Hb tetramer binding one molecule
of NO, which is 1% of the total Hb tetramer. There-
fore the presence of one NO molecule in 1% of the
K-subunits increased the P50 of blood by approx.
10 mmHg, i.e., decreased the oxygen a⁄nity. Fur-
thermore, the Hill coe⁄cient, n, increased from 2.4
to 3.6. These results suggest that the presence of Hb
K-NO enhances O2 release from Hb, which is ampli-
¢ed in erythrocytes through a Hb-facilitated O2 dif-
fusion mechanism, especially in O2-de¢cient tissues.
Under the conditions, no EPR signal of methemo-
globin at g = 6 was observed, probably because the
supply of NO is not rapid and methemoglobin, if
generated, is recycled to a functional ferrous form
by the methemoglobin reductase system. Allosteric
e¡ectors of Hb, including pH, can have important
e¡ects on the oxygen a⁄nity of Hb K-NO, e.g. a
highly enhanced Bohr e¡ect [27]. When control
erythrocytes are mixed with erythrocytes containing
fully NO-ligated Hb, the percentage of NO ligation
can be increased to 50%; under these conditions, the
NO ligand is not restricted to the K-heme and the
a⁄nity of unliganded Hb for O2 will therefore in-
crease [22].
It has been suggested that, because the amount of
Hb K-NO formed in vivo is rather small (less than
several percent of the intra-erythrocyte concentration
of Hb), its impact and contribution toward the over-
all O2 a⁄nity (P50) of the erythrocytes is negligible
[27]. However, we do not agree with this suggestion.
We conducted a study with whole blood [25] which
demonstrates [23] that Hb in solution augments the
di¡usion rate of free O2. The amount of O2 trans-
ported by Hb-facilitated O2 di¡usion in a Hb solu-
tion is several times greater than that by di¡usion of
free O2 (Fig. 4). The rate-limiting step of the Hb-
facilitated O2 di¡usion is ligand dissociation. CO
abolishes the augmented £ux of O2 through Hb sol-
ution, because partial combination of a Hb tetramer
with one CO molecule causes the remaining Hb sub-
units to adhere to O2 with abnormal tenacity
through allosteric interaction [28]. On the contrary,
the partially NO-bound Hb K will enhance the Hb-
facilitated O2 di¡usion in erythrocytes and O2 release
to tissues. Since O2 di¡usion in erythrocytes is also a
barrier in O2 release to tissues, the e¡ect of NO on
Table 1
E¡ect of Hb K-NO on P50 and Hill coe⁄cient, n
Control Nitroglycerin-treated rats
P50 (mmHg) 38 þ 0.8 46 þ 0.9*
n 2.6 þ 0.05 3.7 þ 0.03#
E¡ect of Hb K-NO concentration on oxygen dissociation
curves. The P50 denotes pO2 at 50% of oxygen saturation of
Hb in whole blood. These values were obtained from the Hill
plots, log Y/(13Y) versus log pO2, where Y is the fraction of
oxygenated species. The concentrations of K-NO were 0 and
13 þ 3 in the control (n = 4) and nitroglycerin-treated rats
(n = 4). *P6 0.001, #P6 0.0001 with Student’s t-test. ESR sig-
nal of methemoglobin was not detected at the g = 6 region.
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Hb-facilitated O2 di¡usion may be more than ex-
pected in erythrocytes than in Hb solution.
Stamler et al. reported a dynamic cycle of NO in
which highly reactive SH groups (Cys93) in Hb
L-subunits were S-nitrosylated when erythrocytes
were oxygenated in the lung and the NO groups on
the Cys93 residues were then released by deoxygena-
tion-induced allosteric change during circulation in
organs [26,29,30]. They thus proposed an allosteric
vasoactivity of S-nitrosohemoglobin for control of
vasomotor tone, i.e., increasing blood £ow in periph-
eral circulation by turning on a switch to release NO
or nitrosothiol to blood vessels from the Cys93 res-
idues upon sensing an allosteric change toward the
T state. They proposed the possibility of an equili-
brium between NO binding to heme in the T state
and to the L-chain thiol in the R state [30]. We pro-
posed another mechanism, i.e., the interaction of NO
with Hb K-subunit facilitates O2 release during mi-
crocirculation in organs even in the absence of an
increase in blood in£ow.
3. A balance between NO and O32 in blood vessels
under physiological and pathophysiological
conditions
NO may also be bene¢cial, not only in terms of its
potential in improving O2 transport without accom-
panying signi¢cant increase in tissue blood £ow, but
also in its ability to suppress the prooxidative reac-
tants of the vascular system, e.g., NO-mediated in-
hibition of transendothelial migration by leukocytes
and the antioxidative e¡ects of NO with regard to
ischemia/reperfusion. This is an important consider-
ation when discussing the role of NO donors follow-
ing systemic administration.
4. Inhibition of NOS on leukocyte adhesion
NO protects the endothelium from oxidative stress
and subsequent transendothelial migration of leuko-
cytes [31^34]. Diabetic RBC-induced oxidant stress
leads to transendothelial migration of monocyte-
like HL-60 cells. An inhibitor of NO synthase,
NG-nitro-L-arginine methyl ester (L-NAME), evoked
signi¢cant leukocyte adhesion and emigration ac-
companying mast cell degranulation [31^33]. Since
such adherence and degranulation could be sup-
pressed by SOD, the results lead to the explanation
that endogenously generated NO can prevent super-
oxide (O32 ) from causing mast cell degranulation and
the degranulation promotes adhesion of leukocytes
to postcapillary venules.
However, leukocyte adhesion on mesenteric ven-
ules and emigration to extravascular connective tis-
sue occurred even in genetically mast cell-de¢cient
rats [34]. Because superfusion of the NO synthase
inhibitor into the mesentery induced partial degranu-
lation of mast cells in normal rats, the results suggest
that mast cell partial degranulation and leukocyte
emigration are independent processes. When the re-
verse passive Arthus reaction, characterized by gen-
eralized antigen-antibody complex formation, was in-
duced in the rat mesentery, the immune complex
increased both adhesion and emigration of leuko-
cytes in normal rats but not in mast cell-de¢cient
rats. Therefore oxidative stress directly a¡ects endo-
thelium to induce leukocyte adhesion and emigration
independently of mast cells, while mast cells play an
important role in immunological defence.
5. Ischemic reperfusion Hb
K-NO was detected in blood after ischemia/reper-
fusion. After partial ischemia of the rat pancreas
body and tail for 1 h, Hb K-NO was detected with
EPR in the blood after reperfusion [35]. Further-
more, plasma levels of nitrite plus nitrate in both
the systemic and portal venous blood after reperfu-
sion were signi¢cantly higher than those after sham
operation and ischemia alone. The plasma level of
lipase, a marker of damage to pancreatic exocrine
tissue, was signi¢cantly increased after ischemia/re-
perfusion. The elevated plasma lipase level during
ischemia/reperfusion was augmented by administra-
tion of L-NAME. Because administration of L-
NAME without ischemia/reperfusion decreased the
tissue blood £ow of pancreas and increased the plas-
ma lipase level, norepinephrine was added on pan-
creas to decrease the tissue blood £ow of pancreas.
The plasma lipase level was also increased. These
results indicate that NO generated constitutively in
the physiological state or during pancreatic ischemia/
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reperfusion injury exerts a protective e¡ect by sus-
taining blood £ow on pancreatic exocrine tissues.
NO was increased rapidly in the early phase of
middle cerebral artery occlusion, as demonstrated us-
ing NO electrode measurements [36], while the levels
of nitrite+nitrate [37] and Hb K-NO [15] were in-
creased in rat jugular blood after reperfusion. Ad-
ministration of SOD (5 mg/kg) signi¢cantly increased
the Hb K-NO levels, but not plasma nitrite+nitrate,
suggesting an interaction between NO and superox-
ide during early reperfusion. Curiously the plasma
nitrite+nitrate level and Hb K-NO after the reperfu-
sion were decreased by increasing SOD levels (25 mg/
kg) [38]. Temperature can also have an e¡ect on NO
metabolism in the vasculature. Both Hb K-NO and
nitrite plus nitrate levels under moderate hypother-
mia (approx. 32‡C) were signi¢cantly low compared
with normothermic rats after cerebral ischemia/reper-
fusion [39]. Under these conditions, peroxynitrite for-
mation and tissue injury may be decreased. To sum-
marize, Hb K-NO is produced during ischemic
reperfusion of speci¢c organs and this protective ef-
fect by NO may be mediated via decreasing super-
oxide levels and preventing leukocyte adhesion and
transendothelial migration induced by reactive oxy-
gen species. As discussed earlier, the generated Hb K-
NO will also increase oxyhemoglobin in£ow and
oxygen dissociation to tissues during reperfusion.
Regarding the results with leukocyte adhesion,
under normal conditions a delicate balance exists be-
tween NO, an antioxidant, and the pro-oxidant ele-
ments of the vascular system, O32 , and peroxynitrite
(a by-product of the reaction of NO and superoxide
[40]). This balance can be disrupted in favor of per-
oxynitrite [41] and hydrogen peroxide under the con-
ditions of ischemia/reperfusion. Nitroglycerin may be
bene¢cial as a NO donor, not only in terms of its
potential in improving O2 release, but also in its
ability to suppress the prooxidative forces of the vas-
cular systems. However, chronic administration of
excess nitroglycerin accompanies elevation of angio-
tensin II probably through a feedback mechanism
against the hypotensive e¡ect, which subsequently
increases O32 and endothelin production in the vas-
cular systems and causes tolerance [42]. Chronic ele-
vation of endothelin can induce vascular hypertro-
phy [21]. Since NO, either authentic or derived
from NTG, decreases NOS activity without a¡ecting
NOS protein expression in human platelets [43],
chronic administration of excess nitroglycerin may
also a¡ect activity of vascular endothelial NOS.
Acknowledgements
The original work performed in the laboratory of
the author was supported in part by Grants-in-Aid
from the Ministry of Education, Science and Culture
of Japan and by the Naito Foundation of Japan.
References
[1] D.A. Wagner, V.R. Young, S.R. Tannenbaum, Mammalian
nitrate biosynthesis : incorporation of 15NH3 into nitrate is
enhanced by endotoxin treatment, Proc. Natl. Acad. Sci.
USA 80 (1983) 4518^4521.
[2] D.J. Stuehr, M.A. Marletta, Mammalian nitrate biosynthe-
sis: mouse macrophages produce nitrite and nitrate in re-
sponse to Escherichia coli lipopolysaccharide, Proc. Natl.
Acad. Sci. USA 82 (1985) 7738^7742.
[3] J.B. Hibbs Jr., R.R. Taintor, Z. Vavrin, Macrophage cyto-
toxicity: role for L-arginine deiminase and imino nitrogen
oxidation to nitrite, Science 235 (1987) 473^476.
[4] S. Moncada, Nitric oxide in the vasculature: physiology and
pathophysiology, Ann. NY Acad. Sci. 811 (1997) 60^67.
[5] U. Westenberger, S. Thanner, H.H. Ruf, K. Gersonde, G.
Sutter, O. Trentz, Formation of free radicals and nitric oxide
derivative of hemoglobin in rats during shock syndrome,
Free Radic. Res. Commun. 11 (1990) 167^178.
[6] J.J. Lancaster, J.M. Langrehr, H.A. Bergonia, N. Murase,
R.L. Simmons, R.A. Ho¡man, EPR detection of heme and
nonheme iron-containing protein nitrosylation by nitric ox-
ide during rejection of rat heart allograft, J. Biol. Chem. 267
(1992) 10994^10998.
[7] S. Tanaka, W. Kamiike, T. Ito, F. Uchikoshi, H. Matsuda,
M. Nozawa, E. Kumura, T. Shiga, H. Kosaka, Generation
of nitric oxide as a rejection marker in rat pancreas trans-
plantation, Transplantation 60 (1995) 713^717.
[8] H. Kosaka, Y. Sawai, H. Sakaguchi, E. Kumura, N. Har-
ada, M. Watanabe, T. Shiga, EPR spectral transition by
arteriovenous cycle in nitric oxide hemoglobin of cytokine-
treated rats, Am. J. Physiol. 266 (1994) C1400^C1405.
[9] M. Feelisch, E.A. Noack, Correlation between nitric oxide
formation during degradation of organic nitrates and activa-
tion of guanylate cyclase, Eur. J. Pharmacol. 139 (1987) 19^
30.
[10] T. Shiga, K.-J. Hwang, I. Tyuma, Electron paramagnetic
resonance studies of nitric oxide hemoglobin derivatives. I.
Human hemoglobin subunits, Biochemistry 8 (1969) 378^
383.
BBABIO 44739 26-4-99
H. Kosaka / Biochimica et Biophysica Acta 1411 (1999) 370^377376
[11] H. Rein, O. Ristau, W. Scheler, On the in£uence of allosteric
e¡ectors on the electron paramagnetic spectrum of nitric
oxide hemoglobin, FEBS Lett. 24 (1972) 24^26.
[12] Y. Henry, R. Banerjee, Electron paramagnetic studies of
nitric oxide haemoglobin derivatives: isolated subunits and
nitric oxide hybrids, J. Mol. Biol. 73 (1973) 469^482.
[13] A. Szabo, M.F. Perutz, Equilibrium between six- and ¢ve-
coordinated hemes in nitrosylhemoglobin: interpretation of
electron spin resonance spectra, Biochemistry 15 (1976)
4427^4428.
[14] N. Maeda, K. Imaizumi, K. Kon, T. Shiga, A kinetic study
on functional impairment of nitric oxide-exposed rat eryth-
rocytes, Environ. Health Perspect. 73 (1987) 171^177.
[15] E. Kumura, T. Yoshimine, K.I. Iwatsuki, K. Yamanaka, S.
Tanaka, T. Hayakawa, T. Shiga, H. Kosaka, Generation of
nitric oxide and superoxide during reperfusion after focal
cerebral ischemia in rats, Am. J. Physiol. 270 (1996) C748^
C752.
[16] M.F. Perutz, Stereochemistry of cooperative e¡ects in hae-
moglobin, Nature 228 (1970) 726^739.
[17] R. Cassoly, Q.H. Gibson, Conformation, co-operativity and
ligand binding in human hemoglobin, J. Mol. Biol. 91 (1975)
301^313.
[18] R. Hille, J.S. Olson, G. Palmer, Spectral transitions of nitro-
syl hemes during ligand binding to hemoglobin, J. Biol.
Chem. 254 (1979) 12110^12120.
[19] M. Fujii, H. Hori, G. Miyazaki, H. Morimoto, T. Yonetani,
The porphyrin-iron hybrid hemoglobins. Absence of the Fe-
His bonds in one type of subunits favors a deoxy-like struc-
ture with low oxygen a⁄nity, J. Biol. Chem. 268 (1993)
15386^15393.
[20] C.F. Stevens, Y. Wang, Reversal of long-term potentiation
by inhibitors of haem oxygenase, Nature 364 (1993) 147^
149.
[21] Y. Okada, I. Tyuma, Y. Ueda, T. Sugimoto, E¡ect of car-
bon monoxide on equilibrium between O2 and hemoglobin,
Am. J. Physiol. 230 (1976) 471^475.
[22] K. Kon, N. Maeda, T. Shiga, E¡ect of nitric oxide on the
oxygen transport of human erythrocytes, J. Toxicol. Envi-
ron. Health 2 (1977) 1109^1113.
[23] H. Kosaka, A. Seiyama, Elevation of oxygen release by ni-
troglycerin without an increase in blood £ow in the hepatic
microcirculation, Nat. Med. 3 (1997) 456^459.
[24] H. Kosaka, S. Tanaka, T. Yoshii, E. Kumura, A. Seiyama,
T. Shiga, Direct proof of nitric oxide formation from a ni-
trovasodilator metabolised by erythrocytes, Biochem. Bio-
phys. Res. Commun. 204 (1994) 1055^1060.
[25] H. Kosaka, A. Seiyama, Physiological role of nitric oxide as
an enhancer of oxygen transfer from erythrocytes to tissues,
Biochem. Biophys. Res. Commun. 218 (1996) 749^752.
[26] L. Jia, J. Bonaventura, J.S. Stamler, S-Nitrosohaemoglobin:
a dynamic activity of blood involved in vascular control,
Nature 380 (1996) 221^226.
[27] T. Yonetani, A. Tsuneshige, Y. Zhou, X. Chen, Electron
paramagnetic resonance and oxygen binding studies of a-
nitrosyl hemoglobin, J. Biol. Chem. 273 (1998) 20323^20333.
[28] J.B. Wittenberg, The molecular mechanism of hemoglobin-
facilitated oxygen di¡usion, J. Biol. Chem. 241 (1966) 104^
114.
[29] J.S. Stamler, L. Jia, J.P. Eu, T.J. McMahon, I.T. Demchen-
ko, J. Bonaventura, K. Gernert, C.A. Piantadosi, Blood £ow
regulation by S-nitrosohemoglobin in the physiological oxy-
gen gradient, Science 276 (1997) 2034^2037.
[30] A.J. Gow, J.S. Stamler, Reactions between nitric oxide and
haemoglobin under physiological conditions, Nature 391
(1998) 169^173.
[31] P. Kubes, S. Kanwar, X.F. Niu, J.P. Gaboury, Nitric oxide
synthesis inhibition induces leukocyte adhesion via superox-
ide and mast cells, FASEB J. 7 (1993) 1293^1299.
[32] S. Kanwar, P. Kubes, Nitric oxide is an antiadhesive mole-
cule for leukocytes, New Horiz. 3 (1995) 93^104.
[33] J.P. Gaboury, X.F. Niu, P. Kubes, Nitric oxide inhibits nu-
merous features of mast cell-induced in£ammation, Circula-
tion 93 (1996) 318^326.
[34] H. Kosaka, A. Seiyama, N. Terada, H. Yoneyama, S. Hir-
ota, Y. Kitamura, Absence of mast cell involvement in leu-
kocyte adhesion and emigration induced by inhibition of
nitric oxide synthase, Lab. Invest. 77 (1997) 575^580.
[35] S. Tanaka, W. Kamiike, H. Kosaka, T. Ito, E. Kumura, T.
Shiga, H. Matsuda, Detection of nitric oxide production and
its role in pancreatic ischemia-reperfusion in rats, Am. J.
Physiol. 271 (1996) G405^G409.
[36] T. Malinski, Z. Taha, Nitric oxide release from a single cell
measured in situ by a porphyrinic-based microsensor, Nature
358 (1992) 676^678.
[37] E. Kumura, H. Kosaka, T. Shiga, T. Yoshimine, T. Hay-
akawa, Elevation of plasma nitric oxide end products during
focal cerebral ischemia and reperfusion in the rat, J. Cereb.
Blood Flow Metab. 14 (1994) 487^491.
[38] E. Kumura, T. Yoshimine, S. Kubo, S. Tanaka, T. Hayaka-
wa, T. Shiga, H. Kosaka, E¡ects of superoxide dismutase on
nitric oxide production during reperfusion after focal cere-
bral ischemia is rats, Neurosci. Lett. 200 (1995) 137^140.
[39] E. Kumura, T. Yoshimine, M. Takaoka, T. Hayakawa, T.
Shiga, H. Kosaka, Hypothermia suppresses nitric oxide ele-
vation during reperfusion after focal cerebral ischemia in
rats, Neurosci. Lett. 220 (1996) 45^48.
[40] A.G. Estevez, N. Spear, S.M. Manuel, R. Radi, C.E. Hen-
derson, L. Barbeito, J.S. Beckman, Nitric oxide and super-
oxide contribute to motor neuron apoptosis induced by tro-
phic factor deprivation, J. Neurosci. 18 (1998) 923^931.
[41] N. Fukuyama, S. Takizawa, H. Ishida, K. Hoshiai, Y. Shi-
nohara, H. Nakazawa, Peroxynitrite formation in focal cer-
ebral ischemia-reperfusion in rats occurs predominantly in
the peri-infarct region, J. Cereb. Blood Flow Metab. 18
(1998) 123^129.
[42] T. Munzel, S. Kurz, T. Heitzer, D.G. Harrison, New insights
into mechanisms underlying nitrate tolerance, Am. J. Cardi-
ol. 77 (1996) 24C^30C.
[43] L.Y. Chen, J.L. Mehta, Downregulation of nitric oxide syn-
thase activity in human platelets by nitroglycerin and au-
thentic nitric oxide, J. Invest. Med. 45 (1997) 69^74.
BBABIO 44739 26-4-99
H. Kosaka / Biochimica et Biophysica Acta 1411 (1999) 370^377 377
